Moderna Analyst Price Targets - Benzinga

Moderna Inc

MRNANASDAQ

Trade with Public

Trade with Public

$187.46

-15.75-7.75%

Ult. Agg.: Oct 6, 7:59 PM

$187.65

-15.56-7.66%

Panoramica Notizie Previsioni utili EventiObiettivi di prezzoDati finanziari Sentiment Azionariato Confronta Opzioni Rapporto azionario

© 2026 Benzinga | All Rights Reserved

Moderna Analyst Price Targets - Benzinga

Moderna Analyst Price Targets

Wall Street analyst price targets and consensus rating for Moderna (MRNA).

Price Target Range — 10 Quarters

Analyst Consensus — 18 Analysts

4Buy

9Hold

5Sell

Consensus RatingHold# Analysts18Avg. Consensus PT$72Upside to Avg. PT-61.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 30, 2026	Citigroup	Geoff Meacham	Downgrade	Neutral→Sell	$60→$80
Sep 3, 2026	Rothschild & Co	Simon Baker	Downgrade	Neutral→Sell	$40→$81
Aug 28, 2026	Argus Research	John Eade	Upgrade	Hold→Buy	$180
Aug 25, 2026	Wolfe Research	Alexandria Hammond	Upgrade	Underperform→Peer Perform	—
Aug 24, 2026	Barclays	Eliana Merle	PT Raise	Equal-Weight	$48→$125
Aug 21, 2026	JP Morgan	Jessica Fye	PT Raise	Underweight	$40→$77
Aug 20, 2026	Goldman Sachs	Salveen Richter	PT Raise	Neutral	$67→$120
Aug 20, 2026	UBS	Michael Yee	PT Raise	Neutral	$50→$150
Aug 20, 2026	Morgan Stanley	Terence Flynn	PT Raise	Equal-Weight	$39→$89
Aug 19, 2026	William Blair	Myles Minter	Upgrade	Market Perform→Outperform	—
Aug 3, 2026	Citigroup	Geoff Meacham	PT Raise	Neutral	$41→$60
Jul 21, 2026	Goldman Sachs	Salveen Richter	PT Raise	Neutral	$49→$67
Jul 8, 2026	Morgan Stanley	Matthew Harrison	PT Raise	Equal-Weight	$33→$39
Jul 7, 2026	RBC Capital	Luca Issi	PT Raise	Sector Perform	$38→$45
Jul 7, 2026	B of A Securities	Dimple Gosai	PT Raise	Underperform	$34→$38
Jun 26, 2026	Piper Sandler	Edward Tenthoff	PT Raise	Overweight	$69→$77
Jun 8, 2026	B of A Securities	Dimple Gosai	PT Raise	Underperform	$32→$34
May 4, 2026	UBS	Eliana Merle	PT Raise	Neutral	$36→$45
May 4, 2026	Goldman Sachs	Salveen Richter	PT Raise	Neutral	$43→$49
May 4, 2026	Evercore ISI Group	Cory Kasimov	PT Raise	In-Line	$35→$50

More with Benzinga EdgeGet Access

Analyst Ratings News

This Dow Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

Analysts downgraded SoundThinking, Moderna, Accelerant, Mobileye and Dow, revising their ratings and price targets.

Avi Kapoor

Microsoft To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday

Analysts revised targets and ratings for KMX, ARX, JKHY, MRNA, GO, HNGE, AYTU and MSFT, with mixed upgrades, downgrades and reiterations.

Avi Kapoor

PRO
Citigroup Downgrades Moderna to Sell, Raises Price Target to $80

Citigroup analyst Geoff Meacham downgrades Moderna (NASDAQ:MRNA) from Neutral to Sell and raises the price target from $60 to $80.

Benzinga Newsdesk

This Sonoco Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday

Analysts downgraded Ultragenyx, Moderna and Sonoco; targets fell for RARE and SON but rose for MRNA.

Avi Kapoor

CrowdStrike To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Thursday

Analysts revised price targets for Ultragenyx, UiPath, Netskope, Snowflake, Magnite, Broadcom, CrowdStrike and Moderna; ratings largely maintained.

Avi Kapoor

PRO
Rothschild & Co Downgrades Moderna to Sell, Raises Price Target to $81

Rothschild & Co analyst Simon Baker downgrades Moderna (NASDAQ:MRNA) from Neutral to Sell and raises the price target from $40 to $81.

Benzinga Newsdesk